Brixton Biosciences
Pre-clinicalReneuRx™ therapy from Brixton Biosciences has the potential for long-last pain control from one injection.
Founded
2018
Focus
Pain ManagementMedical DevicesDrug Delivery
About
ReneuRx™ therapy from Brixton Biosciences has the potential for long-last pain control from one injection.
Funding History
1Total raised: $3.5M
Seed$3.5MUndisclosedJun 15, 2020
Company Info
TypePrivate
Founded2018
LocationCambridge, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile